DONGWHA PHARM.CO.,LTD Q3 profit from main business KRW 3.8 billion on sales of KRW 129.9 billion
AI summary · Not investment advice
Dong Wha Pharm sold KRW 129.9 billion in Q3 and earned KRW 3.8 billion from its main business, up 179.5% from a year earlier and down 62.8% from the prior quarter.
Operating profit · 3 months
KRW 3.8 billion
Key facts
- Revenue (3 months)
- KRW 129.9 billion
- Net income (3 months)
- KRW 68.1 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 122.0 billion
- Revenue (year to date)
- KRW 397.5 billion
- Operating profit (prior-year 3 months)
- KRW 1.4 billion
- Operating profit (year to date)
- KRW 25.3 billion
- Net income (prior-year 3 months)
- KRW 241.6 million
- Net income (year to date)
- KRW 16.2 billion
Commentary
AI commentary · Not investment advice
What happened
Dongwha Pharm reported its consolidated results for the third quarter of 2026 (July to September). Sales for the 3 months were KRW 129.9 billion. That is 6.5% higher than the same 3 months a year earlier and 5.1% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 3.8 billion. That is 179.5% higher than a year earlier and 62.8% lower than the previous quarter.
What changes for shareholders
Net income (the final profit after taxes and other costs) for the 3 months was KRW 68.1 million. That is 71.8% lower than a year earlier and 98.9% lower than the previous quarter.
For the year to date (January 1 to September 30), sales were KRW 397.5 billion. Operating profit was KRW 25.3 billion and net income was KRW 16.2 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D